Aggressive wildfire spans more than 70,000 acres and counting, cause unknown DALLAS – July 21,...READ MORE
Hawaii Farmer Sues Monsanto, Claims RoundUp Caused Cancer
A macadamia farmer in Hawaii has sued Monsanto, claiming that the company’s popular weed killer RoundUp caused his cancer diagnosis. The lawsuit was filed February 19 in the U.S. District Court, District of Hawaii. In the complaint, the plaintiff claims that he had used RoundUp on crops many times over a nearly 20-year period.
A Popular – And Potentially Deadly – Product
Monsanto first introduced RoundUp to the public in 1974. Since then it has become an immensely popular product, accounting for approximately $5 billion in revenue for the company during the company’s 2015 fiscal year.
RoundUp works on many types of invasive plants. Its main ingredient, glyphosate, inhibits the presence of a certain enzyme that plants need in order to grow. If a plant does not have the enzyme, it will be unable to generate other proteins necessary to its survival. It will typically die within a few days – some plants will live a few weeks.
The Dangers of Glyphosate
But while glyphosate is an extremely effective weed killer, it has also been linked to the development of multiple forms of cancer, including non-Hodgkin’s lymphoma.
Glyphosate came under intense scrutiny in March 2015 when the World Health Organization announced that it had added the chemical to a list of chemicals it classified as “probable carcinogens.” It did so after an intensive review of 15 years of research studies that examined the link between glyphosate and cancer.
The WHO also found DNA and chromosomal damage in the cells of people who lived near areas where glyphosate was regularly used in large quantities.
There is a growing amount of evidence that RoundUp could pose a substantial risk to human health. If you or someone close to you has suffered non-Hodgkin’s lymphoma after exposure to the product, Baron & Budd may be able to help. Please call 866-223-3424 or complete our contact form for a confidential consultation.